Invention Grant
- Patent Title: DNA vectors, transposons and transposases for eukaryotic genome modification
-
Application No.: US15287624Application Date: 2016-10-06
-
Publication No.: US10041077B2Publication Date: 2018-08-07
- Inventor: Jeremy Minshull , Maggie Lee
- Applicant: DNA2.0, INC.
- Applicant Address: US CA Newark
- Assignee: DNA2.0, INC.
- Current Assignee: DNA2.0, INC.
- Current Assignee Address: US CA Newark
- Agency: Alston & Bird LLP
- Main IPC: C12N15/00
- IPC: C12N15/00 ; C07H21/02 ; C12N15/67 ; C12N15/52 ; C12N15/81 ; C12N15/85 ; C12N9/12 ; C12N15/62 ; C12R1/84 ; C12R1/865 ; C12N15/10 ; C12N15/63

Abstract:
The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.
Public/Granted literature
- US20170101629A1 DNA VECTORS, TRANSPOSONS AND TRANSPOSASES FOR EUKARYOTIC GENOME MODIFICATION Public/Granted day:2017-04-13
Information query
IPC分类: